Question 1

How do reversible and irreversible alpha-receptor antagonists differ in their mechanism?

Accepted Answer

Reversible antagonists are dissociable, allowing high agonist concentrations to overcome their effects. Irreversible antagonists form reactive intermediates that permanently bind to alpha-adrenoceptors and cannot be displaced by additional agonists, providing sustained blockade regardless of agonist concentration.

Question 2

What is the primary mechanism by which alpha-1 blockers lower blood pressure?

Accepted Answer

Alpha-1 blockers inhibit alpha-1 adrenoceptors on smooth muscle cells, causing vasodilation. This widening of blood vessels reduces peripheral vascular resistance and lowers blood pressure, making them effective for hypertension management.

Question 3

How do alpha-1 blockers treat benign prostatic hyperplasia symptoms?

Accepted Answer

Alpha-1 blockers reduce muscle tone in the prostate and bladder neck by inhibiting alpha-1 adrenoceptors on smooth muscle. This relaxation decreases urinary obstruction and alleviates symptoms associated with benign prostatic hyperplasia.

Question 4

What is the effect of alpha-2 blockers on sympathetic neurotransmitter activity?

Accepted Answer

Alpha-2 blockers antagonize presynaptic alpha-2 adrenoceptors, which normally inhibit neurotransmitter release. By blocking these inhibitory receptors, alpha-2 blockers enhance sympathetic neurotransmitter release from presynaptic neurons and activate adrenoceptors of target organs.

Question 5

Why are nonselective alpha-blockers not used for routine hypertension treatment?

Accepted Answer

Nonselective alpha-blockers interact with both alpha-1 and alpha-2 receptors, causing serious side effects that limit their clinical use for hypertension. However, they are prescribed specifically for pheochromocytoma to prevent dangerous blood pressure elevation from catecholamine release.

Question 6

What is pheochromocytoma and why does it cause sustained hypertension?

Accepted Answer

Pheochromocytoma is a tumor of catecholamine-secreting chromaffin cells in the adrenal medulla. Excess catecholamine release from this tumor overstimulates adrenergic receptors throughout the body, leading to sustained elevation of blood pressure.

Question 7

How do alpha-1 and alpha-2 blockers differ in their therapeutic applications?

Accepted Answer

Alpha-1 blockers are used for hypertension and benign prostatic hyperplasia by causing vasodilation and reducing smooth muscle tone. Alpha-2 blockers enhance sympathetic activity and are less commonly used clinically, whereas antagonists pharmacological actions of receptor blockers vary by subtype and clinical indication.

Blokery adrenergiczne: Farmakologiczne działanie blokerów receptorów α

Browse More Videos